Tissue Repair (ASX:TRP) ROCE % : -43.37% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Tissue Repair ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tissue Repair's annualized ROCE % for the quarter that ended in Dec. 2024 was -43.37%.

Tissue Repair ROCE % Historical Data

The historical data trend for Tissue Repair's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Repair ROCE % Chart

Tissue Repair Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

ROCE %

-26.09

-24.31

-32.63

Tissue Repair Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial			-28.24	-21.19	-24.31	-42.09	-43.37

Tissue Repair ROCE % Calculation

Tissue Repair's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	-6.516	/	( ( (22.379 - 0.491)	+	(19.39 - 1.337) )	/ 2 )
	=	-6.516	/	( (21.888	+	18.053)	/ 2 )
	=	-6.516	/	19.9705
	=	-32.63 %

Tissue Repair's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	-7.298	/	( ( (19.39 - 1.337)	+	(16.713 - 1.114) )	/ 2 )
	=	-7.298	/	( ( 18.053	+	15.599 )	/ 2 )
	=	-7.298	/	16.826
	=	-43.37 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

Tissue Repair (ASX:TRP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tissue Repair ROCE % Related Terms

Thank you for viewing the detailed overview of Tissue Repair's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Repair Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Repair Ltd (ASX:TRP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

255 Pitt Street, Level 10, Sydney, NSW, AUS, 2000

Website

https://www.tissuerepair.com.au

Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.